Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Demographic, clinical, and laboratory characteristics of T1DM and T2DM groups according to osteoporosis statusType 1 Diabetes(n = 76,742)Type 2 Diabetes(n = 7,006,910)p§nNo osteoporosis(n = 69,559)nOsteoporosis(n = 7,183)pnNo osteoporosis(n = 5,666,325)nOsteoporosis(n = 1,340,585)pDemographicsAge, years: median (IQR)69,55937 (26)7,18367 (23) < 0.0015,666,32558 (17)1,340,58567 (14) < 0.001 < 0.001Sex, female: n (%)69,55930,170 (43.37%)7,1834,981 (69.34%) < 0.0015,666,3253,051,858 (53.86%)1,340,5851,172,612 (87.47%) < 0.001 < 0.001BMI, kg/m2: median (IQR)6,20825.24 (6.75)70127.55 (7.03) < 0.001442,28230.02 (6.68)115,65430.09 (6.62)0.172 < 0.001Comorbid diseasesHypertension: n (%)69,55933,357 (47.95%)7,1836,262 (87.18%) < 0.0015,666,3254,223,334 (74.53%)1,340,5851,226,028 (91.45%) < 0.001 < 0.001Obesity: n (%)6,2081,261 (20.31%)701227 (32.38%) < 0.001442,282221,439 (50.07%)115,65458,744 (50.79%) < 0.001 < 0.001Dyslipidemia: n (%)69,55936,123 (51.93%)7,1835,204 (72.45%) < 0.0015,666,3253,897,440 (68.78%)1,340,5851,052,212 (78.49%) < 0.001 < 0.001Hypothyroidism: n (%)69,55915,426 (22.18%)7,1832,244 (31.24%) < 0.0015,666,3251,310,511 (23.13%)1,340,585463,451 (34.57%) < 0.001 < 0.001ComplicationsCoronary artery disease: n (%)69,55916,050 (23.07%)7,1834,242 (59.06%) < 0.0015,666,3252,147,185 (37.89%)1,340,585727,500 (54.27%) < 0.001 < 0.001Stroke: n (%)69,5591,971 (2.83%)7,183608 (8.46%) < 0.0015,666,325180,814 (3.19%)1,340,58575,574 (5.64%) < 0.001 < 0.001Peripheral artery disease: n (%)69,5595,249 (7.55%)7,1831,259 (17.53%) < 0.0015,666,325408,621 (7.21%)1,340,585149,648 (11.16%) < 0.001 < 0.001Heart failure: n (%)69,5595,695 (8.19%)7,1831,867 (25.99%) < 0.0015,666,325506,655 (8.94%)1,340,585200,936 (14.99%) < 0.001 < 0.001ASCVD: n (%)69,55918,598 (26.74%)7,1834691 (65.31%) < 0.0015,666,3252,365,884 (41.75%)1,340,585798,885 (59.59%) < 0.001 < 0.001Chronic kidney disease: n (%)42,9527,193 (16.75%)5,2322,167 (41.42%) < 0.0013,433,533485,291 (14.13%)949,584226,223 (23.82%) < 0.001 < 0.001Retinopathy: n (%)69,5595,175 (7.44%)7,183837 (11.65%) < 0.0015,666,325154,469 (2.73%)1,340,58547,445 (3.54%) < 0.001 < 0.001Neuropathy: n (%)69,55916,920 (24.32%)7,1833,241 (45.12%) < 0.0015,666,3251,177,864 (20.79%)1,340,585457,879 (34.16%) < 0.001 < 0.001Any microvascular complications: n (%)69,55923,618 (33.95%)7,1834,513 (62.83%) < 0.0015,666,3251,575,246 (27.8%)1,340,585603,277 (45%) < 0.001 < 0.001Fractures and prosthesesVertebral fracture: n (%)69,55939 (0.06%)7,18340 (0.56%) < 0.0015,666,3254,031 (0.07%)1,340,5854,303 (0.32%) < 0.001 < 0.001Hip fracture: n (%)69,55948 (0.07%)7,18329 (0.4%) < 0.0015,666,3253,171 (0.06%)1,340,5852733 (0.2%) < 0.001 < 0.001Forearm fracture: n (%)69,55911 (0.02%)7,1831 (0.01%)0.6895,666,325528 (0.01%)1,340,585247 (0.02%) < 0.0010.619Hip prosthesis: n (%)69,5595 (0.01%)7,1833 (0.04%)0.0325,666,325460 (0.01%)1,340,585262 (0.02%) < 0.0010.169Knee prosthesis: n (%)69,55910 (0.01%)7,1833 (0.04%)0.1155,666,3252484 (0.04%)1,340,5851681 (0.13%) < 0.0010.042Laboratory testsHbA1c, %: median (IQR)27,0998.45 (2.9)2,9347.8 (2.46) < 0.0012,077,5196.9 (2.45)572,2746.7 (1.85) < 0.001 < 0.001LDL-C, mg/dl: median (IQR)30,137104 (45.8)3,866105 (49.65)0.7012,613,033117 (49)731,374119.5 (50) < 0.001 < 0.001eGFR, mL/min/1.73m2: median (IQR)42,11596.6 (39.13)5,18267.36 (42.38) < 0.0013,419,65285.09 (29.09)946,96176.26 (29.06) < 0.001 < 0.001Creatinine, mg/dl: median (IQR)42,1150.81 (0.32)5,1820.93 (0.51) < 0.0013,419,6520.8 (0.29)946,9610.79 (0.28) < 0.001 < 0.001Calcium, mg/dl: median (IQR)5,9969.4 (0.74)3419.22 (0.8) < 0.001551,0599.45 (0.7)80,8159.49 (0.7) < 0.001 < 0.001Phosphorus, mg/dl: median (IQR)4,4103.5 (0.97)2793.52 (0.92)0.829421,0543.5 (0.8)84,4183.6 (0.8) < 0.0010.125-OH vitamin D, ng/dl: median (IQR)12,84816 (13.8)1,86319.27 (16.6) < 0.001943,58816.77 (13.68)347,95720.25 (16.1) < 0.001 < 0.001iPTH, pg/dl: median (IQR)3,44942 (37.95)54253.08 (63.95) < 0.001186,85848.8 (36.85)79,73550.54 (38.75) < 0.0010.004§Comparison of type 1 and type 2 diabetes in patients with osteoporosis
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this retrospective observational study, data were obtained from the Turkish national electronic health record infrastructure, a unified system used across priamry secondary and tertiary public healthcare institutions in Türkiye.
Source: Methods.
Osteoporosis was diagnosed according to World Health Organization criteria, based on bone mineral density measurements: a T-score ≤ − 2.5 in postmenopausal women or men aged ≥ 55 years, a Z-score ≤ − 2.0 in premenopausal women or younger men, and/or the presence of a fragility fracture.(15).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study
Observational study · Archives of Osteoporosis · 2026
Original publication title
Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Fragility fractures related to diabetes are increasing worldwide with rising life expectancy. We aimed to investigate the prevalence of osteoporosis and its associated factors in a large nationwide cohort of adults with type 1 (T1DM) and type 2 diabetes (T2DM) in Türkiye.
Source: AimAbstract: What methods does the paper describe?
Using Turkish Ministry of Health electronic health records (2015 to 2021), adults with T1DM and T2DM were identified and classified according to the presence or absence of osteoporosis. Demographics, comorbidities, diabetes-related complications, fracture diagnoses, and laboratory parameters were analyzed. Factors independently associated with osteoporosis were evaluated using multivariable logistic regression.
Source: MethodsAbstract: Summary
This nationwide study assessed clinical features of osteoporosis in Turkish adults with diabetes. Osteoporosis prevalence was 9.36% in type 1 diabetes and 19.13% in type 2 diabetes, with higher rates in women and older individuals. Although overall fracture prevalence was low, fractures were markedly more frequent in patients with osteoporosis. Despite the high burden, most patients did not receive osteoporosis therapy, and age, female sex, and vascular complications were independently associated with osteoporosis.
Source: SummaryAbstract: Results
The cohort included 76,742 individuals with T1DM (mean age 44.3 ± 19.1 years; 45.8% women) and 7,006,910 with T2DM (mean age 59.1 ± 13.4 years; 60.2% women). Overall osteoporosis prevalence was 19.03% and was 9.3% in T1DM and 19.1% in T2DM. Osteoporosis was more frequent in women than men (T1DM: 14.17% vs 5.29% p < 0.001; T2DM: 27.76% vs 6.04% p < 0.001) and increased with age in both diabetes types. Fractures occurred in 0.22% of patients with T1DM and 0.21% of those with T2DM.
In T1DM, fracture frequency was approximately sixfold higher in patients with osteoporosis than in those without osteoporosis (RR ≈ 6.92; 95% CI 5.09 to 9.39; p < 0.001), whereas in T2DM osteoporosis was associated with an approximately fourfold higher fracture frequency (RR ≈ 3.98). Macrovascular and microvascular complications were more frequent among osteoporosis patients with T1DM than those with T2DM. Only 13.4% of patients with osteoporosis received pharmacological osteoporosis therapy. In multivariable analysis, older age (OR 1.06), female sex (OR 6.58), cardiovascular disease (OR 1.58), and microvascular complications (OR 1.38) were independently associated with osteoporosis.
Source: ResultsAbstract: Conclusion
In this nationwide Turkish cohort, osteoporosis affected 9.36% of adults with T1DM and 19.13% of those with T2DM. Among patients with osteoporosis, vascular complications were more prevalent in T1DM than in T2DM.Despite the substantial disease burden and the markedly higher fracture frequency in individuals with osteoporosis, most patients remained untreated.
Source: ConclusionAuthors’ abstract
Summary
This nationwide study assessed clinical features of osteoporosis in Turkish adults with diabetes. Osteoporosis prevalence was 9.36% in type 1 diabetes and 19.13% in type 2 diabetes, with higher rates in women and older individuals. Although overall fracture prevalence was low, fractures were markedly more frequent in patients with osteoporosis. Despite the high burden, most patients did not receive osteoporosis therapy, and age, female sex, and vascular complications were independently associated with osteoporosis.
Aim
Fragility fractures related to diabetes are increasing worldwide with rising life expectancy. We aimed to investigate the prevalence of osteoporosis and its associated factors in a large nationwide cohort of adults with type 1 (T1DM) and type 2 diabetes (T2DM) in Türkiye.
Methods
Using Turkish Ministry of Health electronic health records (2015 to 2021), adults with T1DM and T2DM were identified and classified according to the presence or absence of osteoporosis. Demographics, comorbidities, diabetes-related complications, fracture diagnoses, and laboratory parameters were analyzed. Factors independently associated with osteoporosis were evaluated using multivariable logistic regression.
Results
The cohort included 76,742 individuals with T1DM (mean age 44.3 ± 19.1 years; 45.8% women) and 7,006,910 with T2DM (mean age 59.1 ± 13.4 years; 60.2% women). Overall osteoporosis prevalence was 19.03% and was 9.3% in T1DM and 19.1% in T2DM. Osteoporosis was more frequent in women than men (T1DM: 14.17% vs 5.29% p < 0.001; T2DM: 27.76% vs 6.04% p < 0.001) and increased with age in both diabetes types. Fractures occurred in 0.22% of patients with T1DM and 0.21% of those with T2DM.
In T1DM, fracture frequency was approximately sixfold higher in patients with osteoporosis than in those without osteoporosis (RR ≈ 6.92; 95% CI 5.09 to 9.39; p < 0.001), whereas in T2DM osteoporosis was associated with an approximately fourfold higher fracture frequency (RR ≈ 3.98). Macrovascular and microvascular complications were more frequent among osteoporosis patients with T1DM than those with T2DM. Only 13.4% of patients with osteoporosis received pharmacological osteoporosis therapy. In multivariable analysis, older age (OR 1.06), female sex (OR 6.58), cardiovascular disease (OR 1.58), and microvascular complications (OR 1.38) were independently associated with osteoporosis.
Conclusion
In this nationwide Turkish cohort, osteoporosis affected 9.36% of adults with T1DM and 19.13% of those with T2DM. Among patients with osteoporosis, vascular complications were more prevalent in T1DM than in T2DM.Despite the substantial disease burden and the markedly higher fracture frequency in individuals with osteoporosis, most patients remained untreated.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11657-026-01677-x.
Publication and source details
Original title: Clinical features of osteoporosis in patients with type 1 and type 2 diabetes in Türkiye: A nationwide study
Dilek Gogas Yavuz; Cem Haymana; Tolga Akkan; Muhiddin Yalcin; Zeliha Hekimsoy; Ilker Tasci; Mehmet Ali Eren; Naim Ata; Suayip Birinci; Alper Sonmez; Fahri Bayram
Archives of Osteoporosis · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Marmara UniversityOpen access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:56:32.348533+00:00
DOI: 10.1007/s11657-026-01677-x · PMC12929295